Intranasal insulin ameliorates neurological impairment after intracerebral hemorrhage in mice

In Alzheimer’s disease and ischemic stroke, intranasal insulin can act as a neuroprotective agent. However, whether intranasal insulin has a neuroprotective effect in intracerebral hemorrhage and its potential mechanisms remain poorly understood. In this study, a mouse model of autologous blood-indu...

Full description

Bibliographic Details
Main Authors: Yuan Zhu, Yi Huang, Jin Yang, Rong Tu, Xin Zhang, Wei-Wei He, Chang-Yue Hou, Xiao-Ming Wang, Ju-Ming Yu, Guo-Hui Jiang
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2022-01-01
Series:Neural Regeneration Research
Subjects:
Online Access:http://www.nrronline.org/article.asp?issn=1673-5374;year=2022;volume=17;issue=1;spage=210;epage=216;aulast=Zhu
_version_ 1819126805939879936
author Yuan Zhu
Yi Huang
Jin Yang
Rong Tu
Xin Zhang
Wei-Wei He
Chang-Yue Hou
Xiao-Ming Wang
Ju-Ming Yu
Guo-Hui Jiang
author_facet Yuan Zhu
Yi Huang
Jin Yang
Rong Tu
Xin Zhang
Wei-Wei He
Chang-Yue Hou
Xiao-Ming Wang
Ju-Ming Yu
Guo-Hui Jiang
author_sort Yuan Zhu
collection DOAJ
description In Alzheimer’s disease and ischemic stroke, intranasal insulin can act as a neuroprotective agent. However, whether intranasal insulin has a neuroprotective effect in intracerebral hemorrhage and its potential mechanisms remain poorly understood. In this study, a mouse model of autologous blood-induced intracerebral hemorrhage was treated with 0.5, 1, or 2 IU insulin via intranasal delivery, twice per day, until 24 or 72 hours after surgery. Compared with saline treatment, 1 IU intranasal insulin treatment significantly reduced hematoma volume and brain edema after cerebral hemorrhage, decreased blood-brain barrier permeability and neuronal degeneration damage, reduced neurobehavioral deficits, and improved the survival rate of mice. Expression levels of p-AKT and p-GSK3β were significantly increased in the perihematoma tissues after intranasal insulin therapy. Our findings suggest that intranasal insulin therapy can protect the neurological function of mice after intracerebral hemorrhage through the AKT/GSK3β signaling pathway. The study was approved by the Ethics Committee of the North Sichuan Medical College of China (approval No. NSMC(A)2019(01)) on January 7, 2019.
first_indexed 2024-12-22T08:01:53Z
format Article
id doaj.art-1260ad7a76364677944c0ed75f91d94b
institution Directory Open Access Journal
issn 1673-5374
language English
last_indexed 2024-12-22T08:01:53Z
publishDate 2022-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Neural Regeneration Research
spelling doaj.art-1260ad7a76364677944c0ed75f91d94b2022-12-21T18:33:13ZengWolters Kluwer Medknow PublicationsNeural Regeneration Research1673-53742022-01-0117121021610.4103/1673-5374.314320Intranasal insulin ameliorates neurological impairment after intracerebral hemorrhage in miceYuan ZhuYi HuangJin YangRong TuXin ZhangWei-Wei HeChang-Yue HouXiao-Ming WangJu-Ming YuGuo-Hui JiangIn Alzheimer’s disease and ischemic stroke, intranasal insulin can act as a neuroprotective agent. However, whether intranasal insulin has a neuroprotective effect in intracerebral hemorrhage and its potential mechanisms remain poorly understood. In this study, a mouse model of autologous blood-induced intracerebral hemorrhage was treated with 0.5, 1, or 2 IU insulin via intranasal delivery, twice per day, until 24 or 72 hours after surgery. Compared with saline treatment, 1 IU intranasal insulin treatment significantly reduced hematoma volume and brain edema after cerebral hemorrhage, decreased blood-brain barrier permeability and neuronal degeneration damage, reduced neurobehavioral deficits, and improved the survival rate of mice. Expression levels of p-AKT and p-GSK3β were significantly increased in the perihematoma tissues after intranasal insulin therapy. Our findings suggest that intranasal insulin therapy can protect the neurological function of mice after intracerebral hemorrhage through the AKT/GSK3β signaling pathway. The study was approved by the Ethics Committee of the North Sichuan Medical College of China (approval No. NSMC(A)2019(01)) on January 7, 2019.http://www.nrronline.org/article.asp?issn=1673-5374;year=2022;volume=17;issue=1;spage=210;epage=216;aulast=Zhuakt; blood-brain barrier; brain edema; glycogen synthase kinase-3; hematoma; insulin; intracerebral hemorrhage; intranasal insulin; neurological impairment; neuronal degeneration; neuroprotection
spellingShingle Yuan Zhu
Yi Huang
Jin Yang
Rong Tu
Xin Zhang
Wei-Wei He
Chang-Yue Hou
Xiao-Ming Wang
Ju-Ming Yu
Guo-Hui Jiang
Intranasal insulin ameliorates neurological impairment after intracerebral hemorrhage in mice
Neural Regeneration Research
akt; blood-brain barrier; brain edema; glycogen synthase kinase-3; hematoma; insulin; intracerebral hemorrhage; intranasal insulin; neurological impairment; neuronal degeneration; neuroprotection
title Intranasal insulin ameliorates neurological impairment after intracerebral hemorrhage in mice
title_full Intranasal insulin ameliorates neurological impairment after intracerebral hemorrhage in mice
title_fullStr Intranasal insulin ameliorates neurological impairment after intracerebral hemorrhage in mice
title_full_unstemmed Intranasal insulin ameliorates neurological impairment after intracerebral hemorrhage in mice
title_short Intranasal insulin ameliorates neurological impairment after intracerebral hemorrhage in mice
title_sort intranasal insulin ameliorates neurological impairment after intracerebral hemorrhage in mice
topic akt; blood-brain barrier; brain edema; glycogen synthase kinase-3; hematoma; insulin; intracerebral hemorrhage; intranasal insulin; neurological impairment; neuronal degeneration; neuroprotection
url http://www.nrronline.org/article.asp?issn=1673-5374;year=2022;volume=17;issue=1;spage=210;epage=216;aulast=Zhu
work_keys_str_mv AT yuanzhu intranasalinsulinamelioratesneurologicalimpairmentafterintracerebralhemorrhageinmice
AT yihuang intranasalinsulinamelioratesneurologicalimpairmentafterintracerebralhemorrhageinmice
AT jinyang intranasalinsulinamelioratesneurologicalimpairmentafterintracerebralhemorrhageinmice
AT rongtu intranasalinsulinamelioratesneurologicalimpairmentafterintracerebralhemorrhageinmice
AT xinzhang intranasalinsulinamelioratesneurologicalimpairmentafterintracerebralhemorrhageinmice
AT weiweihe intranasalinsulinamelioratesneurologicalimpairmentafterintracerebralhemorrhageinmice
AT changyuehou intranasalinsulinamelioratesneurologicalimpairmentafterintracerebralhemorrhageinmice
AT xiaomingwang intranasalinsulinamelioratesneurologicalimpairmentafterintracerebralhemorrhageinmice
AT jumingyu intranasalinsulinamelioratesneurologicalimpairmentafterintracerebralhemorrhageinmice
AT guohuijiang intranasalinsulinamelioratesneurologicalimpairmentafterintracerebralhemorrhageinmice